Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

349
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Drug Therapy01:28

Drug Therapy

364
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
364
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

669
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
669
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

622
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
622
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

308
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
308
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unseen burden: Exploring caregiver experiences, barriers, and facilitators in foregut cancer care.

Surgical oncology insight·2025
Same author

Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphoma.

Journal of the National Cancer Institute·2025
Same author

Smoking cessation among blood or marrow transplant Survivors: a BMTSS Report.

Bone marrow transplantation·2025
Same author

TTN and BAG3 in Cancer Therapy-Related Cardiomyopathy Among Long-Term Survivors of Childhood Cancer.

JAMA network open·2025
Same author

Burden of Chronic Health Conditions Among People With HIV and Common Non-AIDS-Defining Cancers.

Journal of the National Comprehensive Cancer Network : JNCCN·2025
Same author

Contributions of cancer treatment and genetic predisposition to risk of subsequent neoplasms in long-term survivors of childhood cancer: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study.

The Lancet. Oncology·2025

Related Experiment Video

Updated: Mar 12, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.3K

Optimizing medication adherence in children with cancer.

Sumit Gupta1, Smita Bhatia

  • 1aDivision of Haematology/Oncology, Hospital for Sick Children bFaculty of Medicine, Institute of Health Policy, Management, and Evaluation, and Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada cInstitute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama, USA.

Current Opinion in Pediatrics
|November 1, 2016
PubMed
Summary

Improving medication adherence is crucial for enhancing childhood cancer cure rates. Nonadherence significantly increases relapse risk in pediatric acute lymphoblastic leukemia, highlighting the need for better adherence strategies.

More Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.9K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.6K

Related Experiment Videos

Last Updated: Mar 12, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.3K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.9K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.6K

Area of Science:

  • Pediatric Oncology
  • Pharmacology
  • Public Health

Background:

  • Childhood cancer survival rates have significantly improved.
  • Research has historically focused on disease biology and therapy resistance.
  • The impact of medication nonadherence in pediatric cancer has been understudied.

Purpose of the Study:

  • To highlight the critical role of medication adherence in improving childhood cancer outcomes.
  • To review current understanding and future directions in addressing nonadherence in pediatric cancer treatment.

Main Methods:

  • Review of recent studies on medication adherence in pediatric cancer.
  • Analysis of the link between nonadherence and treatment outcomes, particularly relapse risk.
  • Assessment of current tools and interventions for improving adherence.

Main Results:

  • Nonadherence to oral antimetabolites in pediatric acute lymphoblastic leukemia is linked to increased relapse risk.
  • The effects of nonadherence on other oral medications and cancer types require further investigation.
  • Current methods for identifying nonadherence and interventions to improve it are still under development and validation.

Conclusions:

  • Improving medication adherence is essential for further enhancing childhood cancer cure rates.
  • Future research should prioritize developing and implementing effective methods to identify and minimize nonadherence.
  • Addressing nonadherence is a key strategy to improve treatment success in pediatric oncology.